These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 9325016)

  • 1. Comparison of efficacy of antisense oligomers directed toward TNF-alpha in helper T and macrophage cell lines.
    Taylor MF; Paulauskis JD; Weller DD; Kobzik L
    Cytokine; 1997 Sep; 9(9):672-81. PubMed ID: 9325016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro efficacy of morpholino-modified antisense oligomers directed against tumor necrosis factor-alpha mRNA.
    Taylor MF; Paulauskis JD; Weller DD; Kobzik L
    J Biol Chem; 1996 Jul; 271(29):17445-52. PubMed ID: 8663413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of TNF-alpha antisense oligomers on cytokine production by primary murine alveolar macrophages.
    Taylor MF; Weller DD; Kobzik L
    Antisense Nucleic Acid Drug Dev; 1998 Jun; 8(3):199-205. PubMed ID: 9669657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo evaluation of a morpholino antisense oligomer directed against tumor necrosis factor-alpha.
    Qin G; Taylor M; Ning YY; Iversen P; Kobzik L
    Antisense Nucleic Acid Drug Dev; 2000 Feb; 10(1):11-6. PubMed ID: 10726656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antisense oligonucleotide blockade of tumor necrosis factor-alpha in two murine models of colitis.
    Myers KJ; Murthy S; Flanigan A; Witchell DR; Butler M; Murray S; Siwkowski A; Goodfellow D; Madsen K; Baker B
    J Pharmacol Exp Ther; 2003 Jan; 304(1):411-24. PubMed ID: 12490618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific inhibition of interleukin-10 production in murine macrophage-like cells by phosphorothioate antisense oligonucleotides.
    Arima H; Takahashi M; Aramaki Y; Sakamoto T; Tsuchiya S
    Antisense Nucleic Acid Drug Dev; 1998 Aug; 8(4):319-27. PubMed ID: 9743469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spontaneous and cationic lipid-mediated uptake of antisense oligonucleotides in human monocytes and lymphocytes.
    Hartmann G; Krug A; Bidlingmaier M; Hacker U; Eigler A; Albrecht R; Strasburger CJ; Endres S
    J Pharmacol Exp Ther; 1998 May; 285(2):920-8. PubMed ID: 9580645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of tumor necrosis factor alpha secretion and prevention of liver injury in ethanol-fed rats by antisense oligonucleotides.
    Ponnappa BC; Israel Y; Aini M; Zhou F; Russ R; Cao QN; Hu Y; Rubin R
    Biochem Pharmacol; 2005 Feb; 69(4):569-77. PubMed ID: 15670576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of pamidronate on the stimulation of macrophage TNF-alpha release by ultra-high-molecular-weight polyethylene particles: a role for apoptosis.
    Huk OL; Zukor DJ; Antoniou J; Petit A
    J Orthop Res; 2003 Jan; 21(1):81-7. PubMed ID: 12507583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of tumour necrosis factor-alpha by antisense targeting produces immunophenotypical and morphological changes in injury-activated microglia and macrophages.
    Pearse DD; Pereira FC; Stolyarova A; Barakat DJ; Bunge MB
    Eur J Neurosci; 2004 Dec; 20(12):3387-96. PubMed ID: 15610171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting gene expression in the preimplantation mouse embryo using morpholino antisense oligonucleotides.
    Siddall LS; Barcroft LC; Watson AJ
    Mol Reprod Dev; 2002 Dec; 63(4):413-21. PubMed ID: 12412042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase I trial of ISIS 104838, a 2'-methoxyethyl modified antisense oligonucleotide targeting tumor necrosis factor-alpha.
    Sewell KL; Geary RS; Baker BF; Glover JM; Mant TG; Yu RZ; Tami JA; Dorr FA
    J Pharmacol Exp Ther; 2002 Dec; 303(3):1334-43. PubMed ID: 12438559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hydrogen peroxide induces the production of tumor necrosis factor-alpha in RAW 264.7 macrophage cells via activation of p38 and stress-activated protein kinase.
    Nakao N; Kurokawa T; Nonami T; Tumurkhuu G; Koide N; Yokochi T
    Innate Immun; 2008 Jun; 14(3):190-6. PubMed ID: 18562577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Signaling pathways initiated in macrophages after engagement of type A scavenger receptors.
    Coller SP; Paulnock DM
    J Leukoc Biol; 2001 Jul; 70(1):142-8. PubMed ID: 11435497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of antisense morpholino oligomer targeted to c-myc in prostate cancer xenograft murine model and a Phase I safety study in humans.
    Iversen PL; Arora V; Acker AJ; Mason DH; Devi GR
    Clin Cancer Res; 2003 Jul; 9(7):2510-9. PubMed ID: 12855625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perspectives on antisense therapy for the prevention of restenosis.
    Kipshidze N; Moses J; Shankar LR; Leon M
    Curr Opin Mol Ther; 2001 Jun; 3(3):265-77. PubMed ID: 11497351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of telomerase with human telomerase reverse transcriptase antisense enhances tumor necrosis factor-alpha-induced apoptosis in bladder cancer cells.
    Gao XD; Chen YR
    Chin Med J (Engl); 2007 May; 120(9):755-60. PubMed ID: 17531113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure-activity relationship of alginate oligosaccharides in the induction of cytokine production from RAW264.7 cells.
    Iwamoto M; Kurachi M; Nakashima T; Kim D; Yamaguchi K; Oda T; Iwamoto Y; Muramatsu T
    FEBS Lett; 2005 Aug; 579(20):4423-9. PubMed ID: 16055120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of adenoviral TNF alpha antisense is enhanced by a macrophage specific promoter.
    Sidiropoulos P; Liu H; Mungre S; Anderson L; Thimmapaya B; Pope RM
    Gene Ther; 2001 Feb; 8(3):223-31. PubMed ID: 11313794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of IL-15-stimulated TNF-alpha production by rolipram.
    Kasyapa CS; Stentz CL; Davey MP; Carr DW
    J Immunol; 1999 Sep; 163(5):2836-43. PubMed ID: 10453029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.